MétaCan
Menu
Back to cohort

Pharmacokinetic changes along the developmental trajectory: A view of a clinician

2018· article· en· W3084170112 on OpenAlexaff
Shinya Ito

Bibliographic record

VenueProceedings for Annual Meeting of The Japanese Pharmacological Society · 2018
Typearticle
Languageen
FieldMedicine
TopicPharmaceutical studies and practices
Canadian institutionsSickKids FoundationUniversity of TorontoHospital for Sick Children
Fundersnot available
KeywordsDosingMedicinePopulationPharmacokineticsClinical pharmacologyBody surface areaPediatricsIntensive care medicinePharmacologyInternal medicineEnvironmental health

Abstract

fetched live from OpenAlex

Pharmacokinetics (PK) has been the heart and soul of the discipline of clinical pharmacology. One of the reasons is because PK parameters provide key information necessary to design dosing schedules. Although the clinical relevance of PK information is evident, basic understanding of PK principles among clinicians remains poor, which highlights an important education role clinical pharmacologists need to play. The lack of the general understanding compromises appropriate clinical application of PK data to clinical practice particularly in special populations including infants and children. Difficulties in conducting conventional PK studies in children further intensify their therapeutic orphan status, causing rampant off-label/off-evidence uses of drug. Although the value of population PK allowing opportunistic sampling schedules to circumvent the conventional tight- scheduled sampling-intensive PK methods is widely recognized and advocated for infants and children, consistent efforts need to be made, so that PK information becomes available in a timely manner for this vulnerable population. The pediatric population is characterized by its remarkable transformation from a cluster of cells in the embryonic stage to a mature adult. The developmental trajectory is the hallmark of infants and children, which also poses challenges in PK data acquisition and interpretation. In the neonatal period, drug clearance per body weight (BW) or body surface area (BSA) is generally lower than in the older age groups. Over the following infantile period, drug clearance/BW consistently increases with variable rates among individuals and drugs in question. Specifically, drug-metabolizing enzymes such as CYP3A show relatively developed-expression patterns in the neonatal period, but CYP1A2 takes one year or more to reach an adult level of expression and function per BW or BSA. Due to increased water compartments per BW in the neonatal period, volume of distribution per BW of hydrophilic drugs is larger in this age group than in older age groups. Although the average pictures of these developmental profiles of PK can be described clearly, variations among drugs and individuals along the developmental trajectory are poorly understood. Application of physiologically-based PK modeling may be a first step to deepen our understanding of PK developmental profiles and its variations in the paediatric population.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.282
Threshold uncertainty score0.503

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0010.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.081
GPT teacher head0.383
Teacher spread0.302 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueProceedings for Annual Meeting of The Japanese Pharmacological SocietySame topicPharmaceutical studies and practicesFrench-language works237,207